Neuropsychopharmacology: The Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology

4 valoración promedio
( 2 valoraciones por Goodreads )
 
9780781728379: Neuropsychopharmacology: The Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology

Receive FREE On-Line Access through the American College of Neuropsychopharmacology website when you purchase the book! Simply return the card enclosed in the product shrink wrap. A password will be sent to you via e-mail. For a sample chapter, and to learn more about the ACNP, click here.

Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders.

Nine sections focus on specific groups of disorders--disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer's and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation.


Compatibility:

BlackBerry® OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile™ Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC

"Sinopsis" puede pertenecer a otra edición de este libro.

From The New England Journal of Medicine:

Psychopharmacology as a discipline burst on the scientific horizon as precipitously as the psychotropic drugs that gave rise to the field. At a time of frustration at how psychiatry had lagged behind other fields of medicine in major advances, there appeared in December 1952 a brief report describing the remarkable effects of chlorpromazine, soon appreciated as the first antischizophrenic drug and heralding the class of neuroleptic agents that have truly revolutionized psychiatry. A few years later, imipramine, developed as a "me too" chlorpromazine derivative, was discovered to have remarkable antidepressant actions. By the end of the 1950s, chlordiazepoxide (Librium) and diazepam (Valium) were recognized as genuine antianxiety agents. Thus, in less than 10 years, the clinical treatment of most psychiatric disabilities was radically altered. Besides learning how to administer these agents most effectively, psychiatrists and basic neuroscientists endeavored to elucidate how they act. The contemporaneous development of methods for measuring biogenic amines such as serotonin, norepinephrine, and dopamine led to the discoveries that antidepressants facilitate the actions of these neurotransmitters and that neuroleptic drugs block the selective effects of dopamine. The American College of Neuropsychopharmacology was established in the early 1960s as a unique scientific society, uniting clinicians with basic scientists studying drugs and the brain. In most scientific groups, one of two poles dominates, so that the organization is deemed either a "clinical" or a "basic science" enterprise. Remarkably, for roughly 40 years, the American College of Neuropsychopharmacology has successfully melded the two in roughly equal proportions. One of the products of this marriage has been the publication, about every five years, of a major compendium of advances in the field. Each of these compendiums has been successful, but the current offering, Neuropsychopharmacology: The Fifth Generation of Progress, may well be the finest. All the editors are psychiatrists with backgrounds in both basic and clinical research in psychopharmacology. The book comprises 134 chapters, organized into 13 sections focusing on various areas. The success of the book comes from the selection of distinguished editors for each section and from their selection of optimal chapter authors. The elegance of the book is evident from a review of a few of the sections. Neurotransmitters are the royal road to understanding how psychotropic drugs act, since every major psychoactive agent works through one neurotransmitter or another. Eric Nestler and Ron Duman, who have made substantial contributions themselves, have assembled 17 chapters on different aspects of neurotransmission. George Aghajanian, a leader in the study of how LSD (lysergic acid diethylamide) and other drugs act through biogenic amines, writes on serotonin. Jean-Charles Schwartz, a pioneer in histamine research, addresses this remarkable substance, which in diverse parts of the body modulates allergy, gastric acid secretion, and neurotransmission. Joseph Coyle, whose research links excitatory neurotransmission to Huntington's disease and schizophrenia, updates the status of the excitatory neurotransmitter glutamate. Fred Gage, an authority on neuronal growth, provides a chapter on neurogenesis in the adult brain, one of the hottest areas of modern neuroscience. An innovative section depicts how drugs are discovered, evaluated, and approved by the Food and Drug Administration. Chapter authors in this section detail the ways in which preclinical models mimic mental illness, examine ethical considerations in studying drugs in human subjects, and discuss the design of clinical trials. There is even a chapter on regulatory issues, authored by Paul Leber, formerly director of neuropharmacology at the Food and Drug Administration. Separate sections treat individual disease groups such as schizophrenia, anxiety, affective disorders, Alzheimer's disease, substance abuse, obsessive-compulsive behavior, movement disturbances, and sleep disorders. This last section, edited by David Kupfer, a leading sleep researcher, relates recent important advances. For instance, Emmanuel Mignot, who discovered how abnormalities of the neuropeptide hypocretin (orexin) cause narcolepsy, writes on this disorder. Seasonal affective disorder is reviewed by Alfred Lewy, who has published seminal findings on how light exposure can alleviate symptoms. Clear writing, coupled with rigor and depth of coverage, is evident in almost every chapter. Conveying up-to-date research in an accessible form, this book will be indispensable both for neophytes and for professional psychopharmacologists. Solomon H. Snyder, M.D.
Copyright © 2002 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.

Review:

"The 317 contributors from around the world include the best and the brightest minds from the fields of academic and commercial psychopharmacology....the scope and depth of the material continually evoke the realization that there has been a quantum leap in our knowledge of brain function since the previous edition."

"Sobre este título" puede pertenecer a otra edición de este libro.

Los mejores resultados en AbeBooks

1.

Editorial: LWW
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
Cloud 9 Books
(Wellington, FL, Estados Unidos de America)
Valoración
[?]

Descripción LWW. Hardcover. Estado de conservación: New. 0781728371 New Condition. Nº de ref. de la librería NEW7.0338256

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 52,14
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 4,21
A Estados Unidos de America
Destinos, gastos y plazos de envío

2.

Editorial: LWW (2002)
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 2
Librería
Murray Media
(North Miami Beach, FL, Estados Unidos de America)
Valoración
[?]

Descripción LWW, 2002. Hardcover. Estado de conservación: New. Never used!. Nº de ref. de la librería P110781728371

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 60,85
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 1,68
A Estados Unidos de America
Destinos, gastos y plazos de envío

3.

Kenneth L. Davis (Editor), Dennis Charney (Editor), Joseph T. Coyle (Editor), Charles Nemeroff (Editor)
Editorial: Lippincott Williams & Wilkins (2002)
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
Ergodebooks
(RICHMOND, TX, Estados Unidos de America)
Valoración
[?]

Descripción Lippincott Williams & Wilkins, 2002. Hardcover. Estado de conservación: New. 1. Nº de ref. de la librería DADAX0781728371

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 161,95
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 4,21
A Estados Unidos de America
Destinos, gastos y plazos de envío

4.

Editorial: LWW
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: > 20
Librería
Professional and Academic Bookstore
(Dundee, MI, Estados Unidos de America)
Valoración
[?]

Descripción LWW. Hardcover. Estado de conservación: New. 0781728371 *DELIVERED 1-4 business days after shipping** BRAND-NEW. **DELIVERED FAST! Delivery EAST of the Mississippi River only takes 1-2 BUSINESS DAYS after shipping (EXCEPTION: delivery to FL, ME, VT, NH, and a small area of MA takes 3 BUSINESS DAYS after shipping); orders WEST of the Mississippi are usually delivered within 1-4 BUSINESS DAYS after shipping (small areas of OR and ID can take 5 business days). PLEASE NOTE: UPS does not generally deliver to PO Boxes or APO addresses, so please be sure to give us a physical street address to deliver to; also, unfortunately, we cannot ship this item to Alaska or Hawaii. *(this applies to domestic shipments within the continental U.S. - other destinations may take longer) THANKS!. Nº de ref. de la librería L9780781728379-010917L

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 166,06
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,71
A Estados Unidos de America
Destinos, gastos y plazos de envío

5.

Editorial: LWW (2002)
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
Irish Booksellers
(Rumford, ME, Estados Unidos de America)
Valoración
[?]

Descripción LWW, 2002. Hardcover. Estado de conservación: New. book. Nº de ref. de la librería M0781728371

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 180,21
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

6.

Editorial: Lippincott Williams & Wilkins
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Cantidad: 2
Librería
Majestic Books
(London, ,, Reino Unido)
Valoración
[?]

Descripción Lippincott Williams & Wilkins. Estado de conservación: New. pp. 2080. Nº de ref. de la librería 7583649

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 197,82
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 6,18
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

7.

Kenneth L. Davis
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
Grand Eagle Retail
(Wilmington, DE, Estados Unidos de America)
Valoración
[?]

Descripción 2002. Hardcover. Estado de conservación: New. 5th. Hardcover. Thoroughly updated and completely reorganised for a sharper and more clinical focus, the Fifth Edition of this world renowned classic synthesises the latest advances in basic neurobiology.Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 2080 pages. 4.082. Nº de ref. de la librería 9780781728379

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 223,34
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
A Estados Unidos de America
Destinos, gastos y plazos de envío

8.

Kenneth L. Davis
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
AussieBookSeller
(SILVERWATER, NSW, Australia)
Valoración
[?]

Descripción 2002. Hardcover. Estado de conservación: New. 5th. Hardcover. Thoroughly updated and completely reorganised for a sharper and more clinical focus, the Fifth Edition of this world renowned classic synthesises the latest advances in basic.Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. 2080 pages. 4.082. Nº de ref. de la librería 9780781728379

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 200,14
Convertir moneda

Añadir al carrito

Gastos de envío: EUR 31,22
De Australia a Estados Unidos de America
Destinos, gastos y plazos de envío

9.

Editorial: Lippincott Williams and Wilkins, United States (2002)
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
The Book Depository
(London, Reino Unido)
Valoración
[?]

Descripción Lippincott Williams and Wilkins, United States, 2002. Hardback. Estado de conservación: New. 5th ed.. Language: English . Brand New Book. Receive FREE On-Line Access through the American College of Neuropsychopharmacology website when you purchase the book! Simply return the card enclosed in the product shrink wrap. A password will be sent to you via e-mail. For a sample chapter, and to learn more about the ACNP, click here. Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders. Nine sections focus on specific groups of disorders--disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer s and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation. Compatibility: BlackBerry (R) OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile (TM) Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC. Nº de ref. de la librería AAS9780781728379

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 234,71
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

10.

Editorial: Lippincott Williams and Wilkins, United States (2002)
ISBN 10: 0781728371 ISBN 13: 9780781728379
Nuevos Tapa dura Cantidad: 1
Librería
The Book Depository US
(London, Reino Unido)
Valoración
[?]

Descripción Lippincott Williams and Wilkins, United States, 2002. Hardback. Estado de conservación: New. 5th ed.. Language: English . Brand New Book. Receive FREE On-Line Access through the American College of Neuropsychopharmacology website when you purchase the book! Simply return the card enclosed in the product shrink wrap. A password will be sent to you via e-mail. For a sample chapter, and to learn more about the ACNP, click here. Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of the full spectrum of neuropsychiatric disorders. Nine sections focus on specific groups of disorders--disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer s and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation. Compatibility: BlackBerry (R) OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile (TM) Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC. Nº de ref. de la librería AAS9780781728379

Más información sobre esta librería | Hacer una pregunta a la librería

Comprar nuevo
EUR 235,06
Convertir moneda

Añadir al carrito

Gastos de envío: GRATIS
De Reino Unido a Estados Unidos de America
Destinos, gastos y plazos de envío

Existen otras copia(s) de este libro

Ver todos los resultados de su búsqueda